Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Clasificación en acciones #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Precio por acción
$4.06
Última sincronización: 2024-02-23
Capitalización bursátil
$145.61M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Theseus Pharmaceuticals, Inc. (THRX)

Categoría

Historial del precio de la acción de Theseus Pharmaceuticals, Inc. (THRX)
Precio más alto de cierre: $4.07 el 2024-02-01

Precio más bajo de cierre: $16.20 el 2021-10-01
Historial del precio de la acción de Theseus Pharmaceuticals, Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH